Skip to main content
Caplight Logo









MedMind Technology Co., Ltd.

MedMind Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.medicalmind.cn/

Last Round

Series C

Extension

Sep 1, 2022

Total Funding Raised

$10.93M

Company Overview

MedMind Technology Co., Ltd. is a medical technology company that develops deep learning-based AI software for radiation oncology, including automatic contouring of tumor targets and organs at risk.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Computer Vision, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiotherapy planningauto-contouringmedical imaging AIradiation oncologysoftware as a medical deviceSaMDimage segmentationclinical workflow automationAI radiologydeep learning medicalclinical target volumeCTVorgan-at-risk delineationOARmedical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedMind Technology Co., Ltd. Comparables

Compare MedMind Technology Co., Ltd. with similar companies based on industry and business-model similarity.

MedMind Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LinkingMed
92%
PVmed
88%
Manteia Technologies Co., Ltd.
85%

MedMind Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionSep 1, 2022
Series CJun 21, 2021
Series A ExtensionApr 1, 2019
Series ANov 6, 2018

MedMind Technology Co., Ltd. Investors

Notable investors and investment history

MedMind Technology Co., Ltd. investors
InvestorRounds
Qingsong FundSeries A Extension
Shanghai Shengyu Equity Investment Fund ManagementSeries C
Yijing CapitalSeries C
BioTrack CapitalSeries C
Cherami Investment GroupSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2022

    Cherami Investment Group participated in the round.

  • Jun 21, 2021

    Led by BioTrack Capital with participation from Shanghai Shengyu and Yijing Capital.

MedMind Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MedMind Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedMind Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2019
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?